Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 342 entries
Sorted by: Best Match Show Resources per page
Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Seven Sites, United States, 2010, 2012, and 2014.

Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002)

Christensen DL, Maenner MJ, Bilder D, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Pettygrove SD, Robinson C, Shenouda J, White T, Zahorodny W, Pazol K, Dietz P.
PMID: 30973853
MMWR Surveill Summ. 2019 Apr 12;68(2):1-19. doi: 10.15585/mmwr.ss6802a1.

PROBLEM/CONDITION: Autism spectrum disorder (ASD) is estimated to affect up to 3% of children in the United States. Public health surveillance for ASD among children aged 4 years provides information about trends in prevalence, characteristics of children with ASD,...

Cite
Christensen DL, Maenner MJ, Bilder D, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Seven Sites, United States, 2010, 2012, and 2014. MMWR Surveill Summ. 2019;68(2):1-19doi: 10.15585/mmwr.ss6802a1.
Christensen, D. L., Maenner, M. J., Bilder, D., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., Pettygrove, S. D., Robinson, C., Shenouda, J., White, T., Zahorodny, W., Pazol, K., & Dietz, P. (2019). Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Seven Sites, United States, 2010, 2012, and 2014. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002), 68(2), 1-19. https://doi.org/10.15585/mmwr.ss6802a1
Christensen, Deborah L, et al. "Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Seven Sites, United States, 2010, 2012, and 2014." Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) vol. 68,2 (2019): 1-19. doi: https://doi.org/10.15585/mmwr.ss6802a1
Christensen DL, Maenner MJ, Bilder D, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Pettygrove SD, Robinson C, Shenouda J, White T, Zahorodny W, Pazol K, Dietz P. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Seven Sites, United States, 2010, 2012, and 2014. MMWR Surveill Summ. 2019 Apr 12;68(2):1-19. doi: 10.15585/mmwr.ss6802a1. PMID: 30973853; PMCID: PMC6476327.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in endocrinology

Nongonierma AB, Dellafiora L, Paolella S, Galaverna G, Cozzini P, FitzGerald RJ.
PMID: 29963014
Front Endocrinol (Lausanne). 2018 Jun 14;9:329. doi: 10.3389/fendo.2018.00329. eCollection 2018.

Inhibition of dipeptidyl peptidase IV (DPP-IV) may be exploited to maintain the incretin effect during the postprandial phase. As a result, glycemic regulation and energy homeostasis may be improved. Food protein-derived peptides have been identified as natural agents capable...

Cite
Nongonierma AB, Dellafiora L, Paolella S, et al. . Front Endocrinol (Lausanne). 2018;9:329doi: 10.3389/fendo.2018.00329.
Nongonierma, A. B., Dellafiora, L., Paolella, S., Galaverna, G., Cozzini, P., & FitzGerald, R. J. (2018). . Frontiers in endocrinology, 9329. https://doi.org/10.3389/fendo.2018.00329
Nongonierma, Alice B, et al. "." Frontiers in endocrinology vol. 9 (2018): 329. doi: https://doi.org/10.3389/fendo.2018.00329
Nongonierma AB, Dellafiora L, Paolella S, Galaverna G, Cozzini P, FitzGerald RJ. . Front Endocrinol (Lausanne). 2018 Jun 14;9:329. doi: 10.3389/fendo.2018.00329. eCollection 2018. PMID: 29963014; PMCID: PMC6010526.
Copy Download .nbib Format: NLM
Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data.

EClinicalMedicine

Swart N, Maroni R, Muldrew B, Sasieni P, Fitzgerald RC, Morris S.
PMID: 34195582
EClinicalMedicine. 2021 Jun 18;37:100969. doi: 10.1016/j.eclinm.2021.100969. eCollection 2021 Jul.

BACKGROUND: Esophageal adenocarcinoma has a very poor prognosis unless detected early. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett esophagus, a precursor of esophageal adenocarcinoma. Randomised controlled trial data from the BEST3 trial has shown that...

Cite
Swart N, Maroni R, Muldrew B, et al. Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data. EClinicalMedicine. 2021;37:100969doi: 10.1016/j.eclinm.2021.100969.
Swart, N., Maroni, R., Muldrew, B., Sasieni, P., Fitzgerald, R. C., Morris, S. (2021). Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data. EClinicalMedicine, 37100969. https://doi.org/10.1016/j.eclinm.2021.100969
Swart, Nicholas, et al. "Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data." EClinicalMedicine vol. 37 (2021): 100969. doi: https://doi.org/10.1016/j.eclinm.2021.100969
Swart N, Maroni R, Muldrew B, Sasieni P, Fitzgerald RC, Morris S. Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data. EClinicalMedicine. 2021 Jun 18;37:100969. doi: 10.1016/j.eclinm.2021.100969. eCollection 2021 Jul. PMID: 34195582; PMCID: PMC8225801.
Copy Download .nbib Format: NLM
Determination of the internal pair production branching ratio of .

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine

Pibida L, Zimmerman BE, King L, Fitzgerald R, Bergeron DE, Napoli E, Cessna JT.
PMID: 31683089
Appl Radiat Isot. 2020 Feb;156:108943. doi: 10.1016/j.apradiso.2019.108943. Epub 2019 Oct 15.

The National Institute of Standards and Technology (NIST) measured the internal pair production branching ratio of

Cite
Pibida L, Zimmerman BE, King L, et al. Determination of the internal pair production branching ratio of . Appl Radiat Isot. 2019;156:108943doi: 10.1016/j.apradiso.2019.108943.
Pibida, L., Zimmerman, B. E., King, L., Fitzgerald, R., Bergeron, D. E., Napoli, E., & Cessna, J. T. (2020). Determination of the internal pair production branching ratio of . Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 156108943. https://doi.org/10.1016/j.apradiso.2019.108943
Pibida, L, et al. "Determination of the internal pair production branching ratio of ." Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine vol. 156 (2020): 108943. doi: https://doi.org/10.1016/j.apradiso.2019.108943
Pibida L, Zimmerman BE, King L, Fitzgerald R, Bergeron DE, Napoli E, Cessna JT. Determination of the internal pair production branching ratio of . Appl Radiat Isot. 2020 Feb;156:108943. doi: 10.1016/j.apradiso.2019.108943. Epub 2019 Oct 15. PMID: 31683089.
Copy Download .nbib Format: NLM
Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Sawas T, Zamani SA, Killcoyne S, Dullea A, Wang KK, Iyer PG, Fitzgerald RC, Katzka DA.
PMID: 34757196
Clin Gastroenterol Hepatol. 2021 Oct 29; doi: 10.1016/j.cgh.2021.10.039. Epub 2021 Oct 29.

BACKGROUND & AIMS: Despite extensive Barrett's esophagus (BE) screening efforts, most patients with esophageal adenocarcinoma (EAC) present de novo. It is unclear how much of this problem is the result of insensitivity or poor applications of current screening guidelines....

Cite
Sawas T, Zamani SA, Killcoyne S, et al. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol. 2021;doi: 10.1016/j.cgh.2021.10.039.
Sawas, T., Zamani, S. A., Killcoyne, S., Dullea, A., Wang, K. K., Iyer, P. G., Fitzgerald, R. C., & Katzka, D. A. (2021). Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2021.10.039
Sawas, Tarek, et al. "Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2021). doi: https://doi.org/10.1016/j.cgh.2021.10.039
Sawas T, Zamani SA, Killcoyne S, Dullea A, Wang KK, Iyer PG, Fitzgerald RC, Katzka DA. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol. 2021 Oct 29; doi: 10.1016/j.cgh.2021.10.039. Epub 2021 Oct 29. PMID: 34757196.
Copy Download .nbib Format: NLM
Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence.

Nature genetics

Moody S, Senkin S, Islam SMA, Wang J, Nasrollahzadeh D, Cortez Cardoso Penha R, Fitzgerald S, Bergstrom EN, Atkins J, He Y, Khandekar A, Smith-Byrne K, Carreira C, Gaborieau V, Latimer C, Thomas E, Abnizova I, Bucciarelli PE, Jones D, Teague JW, Abedi-Ardekani B, Serra S, Scoazec JY, Saffar H, Azmoudeh-Ardalan F, Sotoudeh M, Nikmanesh A, Poustchi H, Niavarani A, Gharavi S, Eden M, Richman P, Campos LS, Fitzgerald RC, Ribeiro LF, Soares-Lima SC, Dzamalala C, Mmbaga BT, Shibata T, Menya D, Goldstein AM, Hu N, Malekzadeh R, Fazel A, McCormack V, McKay J, Perdomo S, Scelo G, Chanudet E, Humphreys L, Alexandrov LB, Brennan P, Stratton MR.
PMID: 34663923
Nat Genet. 2021 Nov;53(11):1553-1563. doi: 10.1038/s41588-021-00928-6. Epub 2021 Oct 18.

Esophageal squamous cell carcinoma (ESCC) shows remarkable variation in incidence that is not fully explained by known lifestyle and environmental risk factors. It has been speculated that an unknown exogenous exposure(s) could be responsible. Here we combine the fields...

Cite
Moody S, Senkin S, Islam SMA, et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet. 2021;53(11):1553-1563doi: 10.1038/s41588-021-00928-6.
Moody, S., Senkin, S., Islam, S. M. A., Wang, J., Nasrollahzadeh, D., Cortez Cardoso Penha, R., Fitzgerald, S., Bergstrom, E. N., Atkins, J., He, Y., Khandekar, A., Smith-Byrne, K., Carreira, C., Gaborieau, V., Latimer, C., Thomas, E., Abnizova, I., Bucciarelli, P. E., Jones, D., Teague, J. W., Abedi-Ardekani, B., Serra, S., Scoazec, J. Y., Saffar, H., Azmoudeh-Ardalan, F., Sotoudeh, M., Nikmanesh, A., Poustchi, H., Niavarani, A., Gharavi, S., Eden, M., Richman, P., Campos, L. S., Fitzgerald, R. C., Ribeiro, L. F., Soares-Lima, S. C., Dzamalala, C., Mmbaga, B. T., Shibata, T., Menya, D., Goldstein, A. M., Hu, N., Malekzadeh, R., Fazel, A., McCormack, V., McKay, J., Perdomo, S., Scelo, G., Chanudet, E., Humphreys, L., Alexandrov, L. B., Brennan, P., & Stratton, M. R. (2021). Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nature genetics, 53(11), 1553-1563. https://doi.org/10.1038/s41588-021-00928-6
Moody, Sarah, et al. "Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence." Nature genetics vol. 53,11 (2021): 1553-1563. doi: https://doi.org/10.1038/s41588-021-00928-6
Moody S, Senkin S, Islam SMA, Wang J, Nasrollahzadeh D, Cortez Cardoso Penha R, Fitzgerald S, Bergstrom EN, Atkins J, He Y, Khandekar A, Smith-Byrne K, Carreira C, Gaborieau V, Latimer C, Thomas E, Abnizova I, Bucciarelli PE, Jones D, Teague JW, Abedi-Ardekani B, Serra S, Scoazec JY, Saffar H, Azmoudeh-Ardalan F, Sotoudeh M, Nikmanesh A, Poustchi H, Niavarani A, Gharavi S, Eden M, Richman P, Campos LS, Fitzgerald RC, Ribeiro LF, Soares-Lima SC, Dzamalala C, Mmbaga BT, Shibata T, Menya D, Goldstein AM, Hu N, Malekzadeh R, Fazel A, McCormack V, McKay J, Perdomo S, Scelo G, Chanudet E, Humphreys L, Alexandrov LB, Brennan P, Stratton MR. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet. 2021 Nov;53(11):1553-1563. doi: 10.1038/s41588-021-00928-6. Epub 2021 Oct 18. PMID: 34663923.
Copy Download .nbib Format: NLM
Physiology and Pathophysiology of Oxygen Sensitivity.

Antioxidants (Basel, Switzerland)

Fitzgerald RS, Rocher A.
PMID: 34356347
Antioxidants (Basel). 2021 Jul 12;10(7). doi: 10.3390/antiox10071114.

Oxygen is an essential requirement for metabolism in mammals and many other animals. Therefore, pathways that sense a reduction in available oxygen are critical for organism survival. Higher mammals developed specialized organs to detect and respond to changes in...

Cite
Fitzgerald RS, Rocher A. Physiology and Pathophysiology of Oxygen Sensitivity. Antioxidants (Basel). 2021;10(7)doi: 10.3390/antiox10071114.
Fitzgerald, R. S., & Rocher, A. (2021). Physiology and Pathophysiology of Oxygen Sensitivity. Antioxidants (Basel, Switzerland), 10(7), . https://doi.org/10.3390/antiox10071114
Fitzgerald, Robert S, and Rocher, Asuncion. "Physiology and Pathophysiology of Oxygen Sensitivity." Antioxidants (Basel, Switzerland) vol. 10,7 (2021). doi: https://doi.org/10.3390/antiox10071114
Fitzgerald RS, Rocher A. Physiology and Pathophysiology of Oxygen Sensitivity. Antioxidants (Basel). 2021 Jul 12;10(7). doi: 10.3390/antiox10071114. PMID: 34356347; PMCID: PMC8301064.
Copy Download .nbib Format: NLM
Signatures of COVID-19 severity and immune response in the respiratory tract microbiome.

medRxiv : the preprint server for health sciences

Merenstein C, Liang G, Whiteside SA, Cobián-Güemes AG, Merlino MS, Taylor LJ, Glascock A, Bittinger K, Tanes C, Graham-Wooten J, Khatib LA, Fitzgerald AS, Reddy S, Baxter AE, Giles JR, Oldridge DA, Meyer NJ, Wherry EJ, McGinniss JE, Bushman FD, Collman RG.
PMID: 33851179
medRxiv. 2021 Apr 05; doi: 10.1101/2021.04.02.21254514.

RATIONALE: Viral infection of the respiratory tract can be associated with propagating effects on the airway microbiome, and microbiome dysbiosis may influence viral disease.OBJECTIVE: To define the respiratory tract microbiome in COVID-19 and relationship disease severity, systemic immunologic features,...

Cite
Merenstein C, Liang G, Whiteside SA, et al. Signatures of COVID-19 severity and immune response in the respiratory tract microbiome. medRxiv. 2021;doi: 10.1101/2021.04.02.21254514.
Merenstein, C., Liang, G., Whiteside, S. A., Cobián-Güemes, A. G., Merlino, M. S., Taylor, L. J., Glascock, A., Bittinger, K., Tanes, C., Graham-Wooten, J., Khatib, L. A., Fitzgerald, A. S., Reddy, S., Baxter, A. E., Giles, J. R., Oldridge, D. A., Meyer, N. J., Wherry, E. J., McGinniss, J. E., Bushman, F. D., & Collman, R. G. (2021). Signatures of COVID-19 severity and immune response in the respiratory tract microbiome. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.04.02.21254514
Merenstein, Carter, et al. "Signatures of COVID-19 severity and immune response in the respiratory tract microbiome." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.04.02.21254514
Merenstein C, Liang G, Whiteside SA, Cobián-Güemes AG, Merlino MS, Taylor LJ, Glascock A, Bittinger K, Tanes C, Graham-Wooten J, Khatib LA, Fitzgerald AS, Reddy S, Baxter AE, Giles JR, Oldridge DA, Meyer NJ, Wherry EJ, McGinniss JE, Bushman FD, Collman RG. Signatures of COVID-19 severity and immune response in the respiratory tract microbiome. medRxiv. 2021 Apr 05; doi: 10.1101/2021.04.02.21254514. PMID: 33851179; PMCID: PMC8043476.
Copy Download .nbib Format: NLM
The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage.

Eplasty

Fitzgerald RH, Mills JL, Joseph W, Armstrong DG.
PMID: 19436764
Eplasty. 2009;9:e15. Epub 2009 May 05.

OBJECTIVE: People with diabetes are prone to develop lower-extremity ulcerations and infections, both of which serve as major risk factors for limb amputation. The development of lower-extremity complications of diabetes is associated with increased morbidity and mortality. Recently, there...

Cite
Fitzgerald RH, Mills JL, Joseph W, et al. The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage. Eplasty. 2009;9:e15
Fitzgerald, R. H., Mills, J. L., Joseph, W., & Armstrong, D. G. (2009). The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage. Eplasty, 9e15.
Fitzgerald, Ryan H, et al. "The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage." Eplasty vol. 9 (2009): e15.
Fitzgerald RH, Mills JL, Joseph W, Armstrong DG. The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage. Eplasty. 2009;9:e15. Epub 2009 May 05. PMID: 19436764; PMCID: PMC2680239.
Copy Download .nbib Format: NLM
Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 1 liquid chromatography - tandem mass spectrometry (LC-MS/MS) assays - impact of 3-epi-25-hydroxyvitamin D.

Analytical and bioanalytical chemistry

Wise SA, Camara JE, Burdette CQ, Hahm G, Nalin F, Kuszak AJ, Merkel J, Durazo-Arvizu RA, Williams EL, Hoofnagle AN, Ivison F, Fischer R, van den Ouweland JMW, Ho CS, Law EWK, Simard JN, Gonthier R, Holmquist B, Meadows S, Cox L, Robyak K, Creer MH, Fitzgerald R, Clarke MW, Breen N, Lukas P, Cavalier É, Sempos CT.
PMID: 34432104
Anal Bioanal Chem. 2022 Jan;414(1):333-349. doi: 10.1007/s00216-021-03576-1. Epub 2021 Aug 25.

An interlaboratory comparison study was conducted by the Vitamin D Standardization Program (VDSP) to assess the performance of liquid chromatography - tandem mass spectrometry (LC-MS/MS) assays used for the determination of serum total 25-hydroxyvitamin D (25(OH)D), which is the...

Cite
Wise SA, Camara JE, Burdette CQ, et al. Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 1 liquid chromatography - tandem mass spectrometry (LC-MS/MS) assays - impact of 3-epi-25-hydroxyvitamin D. Anal Bioanal Chem. 2021;414(1):333-349doi: 10.1007/s00216-021-03576-1.
Wise, S. A., Camara, J. E., Burdette, C. Q., Hahm, G., Nalin, F., Kuszak, A. J., Merkel, J., Durazo-Arvizu, R. A., Williams, E. L., Hoofnagle, A. N., Ivison, F., Fischer, R., van den Ouweland, J. M. W., Ho, C. S., Law, E. W. K., Simard, J. N., Gonthier, R., Holmquist, B., Meadows, S., Cox, L., Robyak, K., Creer, M. H., Fitzgerald, R., Clarke, M. W., Breen, N., Lukas, P., Cavalier, �. �., & Sempos, C. T. (2022). Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 1 liquid chromatography - tandem mass spectrometry (LC-MS/MS) assays - impact of 3-epi-25-hydroxyvitamin D. Analytical and bioanalytical chemistry, 414(1), 333-349. https://doi.org/10.1007/s00216-021-03576-1
Wise, Stephen A, et al. "Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 1 liquid chromatography - tandem mass spectrometry (LC-MS/MS) assays - impact of 3-epi-25-hydroxyvitamin D." Analytical and bioanalytical chemistry vol. 414,1 (2022): 333-349. doi: https://doi.org/10.1007/s00216-021-03576-1
Wise SA, Camara JE, Burdette CQ, Hahm G, Nalin F, Kuszak AJ, Merkel J, Durazo-Arvizu RA, Williams EL, Hoofnagle AN, Ivison F, Fischer R, van den Ouweland JMW, Ho CS, Law EWK, Simard JN, Gonthier R, Holmquist B, Meadows S, Cox L, Robyak K, Creer MH, Fitzgerald R, Clarke MW, Breen N, Lukas P, Cavalier É, Sempos CT. Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 1 liquid chromatography - tandem mass spectrometry (LC-MS/MS) assays - impact of 3-epi-25-hydroxyvitamin D. Anal Bioanal Chem. 2022 Jan;414(1):333-349. doi: 10.1007/s00216-021-03576-1. Epub 2021 Aug 25. PMID: 34432104.
Copy Download .nbib Format: NLM
The Contribution of Anxiety Sensitivity to Obsessive-Compulsive and Anxiety Symptoms in a Naturalistic Treatment Setting.

Cognitive therapy and research

Kaczkurkin AN, Fitzgerald H, Tyler J, Asnaani A.
PMID: 34135537
Cognit Ther Res. 2018 Oct;42(5):661-673. doi: 10.1007/s10608-018-9909-6. Epub 2018 Mar 30.

Anxiety sensitivity, a fear of arousal-related sensations, is prevalent in a number of disorders. We examined the relationship between internalizing symptoms and the anxiety sensitivity components of physical, social, and cognitive concerns in a sample of 165 patients seeking...

Cite
Kaczkurkin AN, Fitzgerald H, Tyler J, et al. The Contribution of Anxiety Sensitivity to Obsessive-Compulsive and Anxiety Symptoms in a Naturalistic Treatment Setting. Cognit Ther Res. 2018;42(5):661-673doi: 10.1007/s10608-018-9909-6.
Kaczkurkin, A. N., Fitzgerald, H., Tyler, J., & Asnaani, A. (2018). The Contribution of Anxiety Sensitivity to Obsessive-Compulsive and Anxiety Symptoms in a Naturalistic Treatment Setting. Cognitive therapy and research, 42(5), 661-673. https://doi.org/10.1007/s10608-018-9909-6
Kaczkurkin, Antonia N, et al. "The Contribution of Anxiety Sensitivity to Obsessive-Compulsive and Anxiety Symptoms in a Naturalistic Treatment Setting." Cognitive therapy and research vol. 42,5 (2018): 661-673. doi: https://doi.org/10.1007/s10608-018-9909-6
Kaczkurkin AN, Fitzgerald H, Tyler J, Asnaani A. The Contribution of Anxiety Sensitivity to Obsessive-Compulsive and Anxiety Symptoms in a Naturalistic Treatment Setting. Cognit Ther Res. 2018 Oct;42(5):661-673. doi: 10.1007/s10608-018-9909-6. Epub 2018 Mar 30. PMID: 34135537; PMCID: PMC8204905.
Copy Download .nbib Format: NLM
A cross-sectional survey on respiratory disease in a cohort of Irish pig farms.

Irish veterinary journal

Rodrigues da Costa M, Fitzgerald RM, Manzanilla EG, O'Shea H, Moriarty J, McElroy MC, Leonard FC.
PMID: 33319705
Ir Vet J. 2020 Nov 21;73(1):24. doi: 10.1186/s13620-020-00176-w.

BACKGROUND: Respiratory disease is one of the most important factors impacting pig production worldwide. There is no available information on the prevalence of key pathogens implicated in Irish pig production. The objective of this study was to describe the...

Cite
Rodrigues da Costa M, Fitzgerald RM, Manzanilla EG, et al. A cross-sectional survey on respiratory disease in a cohort of Irish pig farms. Ir Vet J. 2020;73(1):24doi: 10.1186/s13620-020-00176-w.
Rodrigues da Costa, M., Fitzgerald, R. M., Manzanilla, E. G., O'Shea, H., Moriarty, J., McElroy, M. C., & Leonard, F. C. (2020). A cross-sectional survey on respiratory disease in a cohort of Irish pig farms. Irish veterinary journal, 73(1), 24. https://doi.org/10.1186/s13620-020-00176-w
Rodrigues da Costa, Maria, et al. "A cross-sectional survey on respiratory disease in a cohort of Irish pig farms." Irish veterinary journal vol. 73,1 (2020): 24. doi: https://doi.org/10.1186/s13620-020-00176-w
Rodrigues da Costa M, Fitzgerald RM, Manzanilla EG, O'Shea H, Moriarty J, McElroy MC, Leonard FC. A cross-sectional survey on respiratory disease in a cohort of Irish pig farms. Ir Vet J. 2020 Nov 21;73(1):24. doi: 10.1186/s13620-020-00176-w. PMID: 33319705; PMCID: PMC7680599.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 342 entries